Advisory Research Inc Nektar Therapeutics Transaction History

Advisory Research Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $1.16 Million - $2.61 Million	-25,028 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$57.4 - $108.44 $658,894 - $1.24 Million	-11,479 Reduced 31.44%	25,028 $2.66 Million
Q4 2017 Feb 08, 2018	SELL	$23.02 - $60.5 $229,578 - $603,366	-9,973 Reduced 21.46%	36,507 $2.18 Million
Q3 2017 Nov 14, 2017	BUY	$17.79 - $24.0 $826,879 - $1.12 Million	46,480	46,480 $1.12 Million

126

109M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $259M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.